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Abstract.  ImmunologicaUy cross-reactive isoforms of 
the cytoskeletal element protein 4.1 have been 
identified in many tissues in which they exhibit hetero- 
geneity of molecular weight, abundance,  and intracel- 
lular localization.  To examine the basis for isoform 
production in erythroid and nonerythroid tissues, we 
have compared the structure and expression of cDNAs 
isolated from human erythroid and nonerythroid 
sources. We have encountered cDNAs representing 
many distinct mRNA sequences. These exhibit com- 
plete nucleotide sequence homology along most of 
their lengths.  Differences were confined to five se- 
quence blocks designated Motifs I-V, which were pres- 
ent or absent in each mRNA moiety. Motif I was ex- 
pressed only in erythroid cells; it encodes 21 amino 
acids in a well-characterized spectrin/actin binding do- 
main.  Motif II, located near the COOH terminus of 
the 80-kD "erythroid" protein 4.1  molecule is present 
in the vast majority of transcripts  from both erythroid 
and nonerythroid cells.  Motifs IV and V  alter the 5' 
untranslated  region:  simultaneous insertion of Motif 
IV and deletion of Motif V  in the untranslated  region 
inserts a new initiator methionine and establishes a 
contiguous open reading frame encoding a novel 135- 
kD protein 4.1 molecule. By immunochemical analysis 
we have identified the longer isoform in cells. Our 
results are most consistent with tissue-specific alterna- 
tive mRNA splicing of transcripts  of the protein 4.1 
gene to yield numerous isoforms. These isoforms ex- 
hibit tissue specificity and alter strategic portions of 
the molecule. Moreover, we describe a novel high mo- 
lecular weight form of protein 4.1 that arises by splic- 
ing events which allow translation  at an upstream site. 
p 
ROTEIN 4.1 is an 80-kD sulfhydryl-rich  phosphopro- 
tein originally  described on the basis of its electro- 
phoretic mobility in cytoskeletal preparations  of ma- 
ture human red cells.  In erythrocytes, protein 4.1 has been 
shown to be important  for maintenance  of the structural  in- 
tegrity and flexibility of the red cell membrane and its under- 
lying cytoskeleton (for reviews see Marchesi, 1985; Bennett, 
1985). Hereditary defects in the quantity or structure of pro- 
tein 4.1  are associated with congenital  hemolytic anemias 
(Tchernia  et  al.,  1981; Conboy  et  al.,  1986b).  Limited 
chymotryptic digestion  of erythroid  protein  4.1  (Fig.  1) 
yields four fragments,  two of which have been tentatively 
identified  as  supporting  known functions of the molecule 
(Leto et al., 1986a). The amino-terminal  30-kD domain ap- 
pears to bind the transmembrane  protein glycophorin in the 
presence oftriphosphoinositides (Leto et al., 1986a), where- 
as the 10-kD domain has been clearly shown to include the 
site for binding to complexes of erythroid spectrin and actin 
(Correas et al.,  1986a,b).  These dual binding  sites  imply 
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that protein 4.1 in erythrocytes serves as a linking molecule, 
attaching the spectrin/actin  cytoskeletal  scaffold to the lipid 
bilayer by means of the cytoplasmic  domains of transmem- 
brane proteins. 
Numerous immunochemical  studies have identified cross- 
reactive forms of protein 4.1 in most tissues. These isoforms 
exhibit remarkable diversity  with regard to the numbers of 
discrete molecular weight forms present in each tissue, and 
their intracellular  localization  (Cohen et al.,  1982; Spiegel 
et al.,  1984;  Aster et al.,  1984;  Granger  and  Lazarides, 
1984;  Goodman  et  al.,  1984;  Davies  and  Cohen,  1985; 
Baines and Bennett,  1985; Leto et al.,  1986b; Tang et al., 
1988).  In nonerythroid tissues,  protein 4.1  appears to be 
prominent  in the nucleus  (Tang, T. K., E. J. Benz, Jr., and 
V. T. Marchesi, manuscript in preparation),  in intracytoplas- 
mic fibrillar networks (Cohen et al., 1982), or in the perinu- 
clear region (Leto et al.,  1986b) as well as in the subplas- 
malemma.  These findings suggest that erythroid protein 4.1 
is the prototype of either a large gene family or a large pro- 
tein family arising from a single gene by alternative process- 
ing of mRNA and/or protein products.  Recently, Conboy et 
al., (1986a) reported the cDNA sequence encoding a protein 
4.1 isolated from a reticulocyte cDNA library. We (Tang et 
al., 1988) and others (Ngai et al., 1987; Conboy et al., 1988) 
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Figure 1.  A molecular model of human erythrocyte protein 4.1 
deduced from limited proteolytic digestions and chemical degrada- 
tion studies (Leto et al.,  1986a). 
have subsequently presented evidence that nonerythroid and 
erythroid protein 4.1 exhibited discrete regional differences 
in mRNA structure that most likely arise by alternate mRNA 
splicing. 
In this report, we describe results of a more detailed com- 
parison of mRNAs encoded by erythroid and nonerythroid 
(lymphoid) cells. To our surprise, we encountered sequence 
motifs inserted or deleted not only into the protein coding 
regions of these mRNAs, but also into the 5' untranslated re- 
gion of the prototypical reticulocyte mRNA. When two such 
splicing  events occur in  concert,  a  novel high  molecular 
weight protein 4.1 isoform is generated; this isoform appears 
to localize both in the nucleus and along the submembranous 
sites at intercellular junctions (Tang, T. K., E. J. Benz, Jr., 
and V. T. Marchesi, manuscript in preparation), suggesting 
that this family of protein 4.1 isoforms can serve as a struc- 
tural component within the nucleus as well as being part of 
the membranous cytoskeleton. In addition, we have found 
distinctly nonrandom accumulations of mRNAs containing 
or lacking specific motifs in different tissues. The tissue-spe- 
cific expression of several motifs is consistent with their pu- 
tative functions. 
Materials and Methods 
Cell Culture 
MOLT 4,  K562,  HEL,  uninduced and DMSO-induced MEL cells were 
maintained in the medium as previously described (Tang  et al.,  1988). 
HeLa cells were maintained in DME supplemented with 10% FCS, 2 mM 
L-glutamine, 100 tt/ml penicillin, and  100 Ug/ml streptomycin. 
Isolation  and DNA Sequence Analysis of Protein 4.1 
eDNA Clones 
Protein 4.1-specific clones were isolated from MOLT 4 (Tang et al., 1988), 
and human fetal liver and bone marrow cDNA libraries (kindly provided 
by Dr. B. Forget, Yale University). These libraries were screened with pro- 
tein 4.l-specific eDNA probes (pTM-I and -2) which have been reported 
previously (Tang et ai., 1988). eDNA inserts from the positive clones were 
subeloned into pGEM-7Zf(+) (Promega Biotec, Madison, Wl) or blue- 
script (Stratagene,  La  Jolla,  CA) vectors which permit direct dideoxy- 
nucleotide sequencing of inserted DNA. Double-strand DNA sequencing 
was performed using GemSeq K/RT sequencing kit (Promega Biotec). To 
identify the sequence motifs within the eDNA clone, a series of synthetic 
oligonucleotides that are flanked by motif sequences were made. The syn- 
thetic oligonucleotides used for this purpose are shown in Table  I. 
The synthetic oligonucleotides were assembled on a  DNA synthesizer 
(Applied Biosystems, Inc., Foster City, CA) and purified as described (Tang 
et al., 1988). These short oligonucleotides were used as sequencing primers 
to obtain the nucleotide sequence of specific sequence motifs in the clones. 
RNA Isolation  and Blot Hybridization 
Total  and poly(A)  + RNAs isolated from cultured cell lines, leukocytes of 
a chronic myelogenous leukemia patient, and reticulocytes were prepared 
as described (Tang et al., 1988). Poly(A)  + RNAs were fractionated  on 1.4% 
agarose formaldehyde gels, followed by transfer to Nytran filters (Schleicher 
&  Schuell, Inc., Keene, NH) and hybridization to pTM-1 eDNA probe. 
Conditions for hybridization and washing were performed as previously de- 
scribed (Tang et al.,  1988). 
RNase Protection Analysis 
30/~g total RNA was hybridized to the antisense probes (see Fig. 4), fol- 
lowed by digestion with RNase A and TI, using a modification of previously 
described methods (Zinn et al.,  1983).  Briefly, 30 ttg dried RNA samples 
were dissolved in 30 #1 of formamide hybridization buffer (80%  forma- 
mide/40 mM Pipes, pH 6.7/0.4 M NaCI/I  mM EDTA)  containing the an- 
tisense probe (5 x  105 cpm), heated at 95°C for 10 rain, and incubated at 
45°C overnight. After hybridization, 300/~1 of RNase digestion buffer (10 
mM Tris-HCl, pH 7.5/5  mM EDTA/300 mM NaCI) containing 40/~g of 
RNase A and 3 p.g of  Tl was added. RNase digestion was performed at 30°C 
for 1 h. The reaction was stopped by the addition of 20 ~1 of 10% SDS and 
50/zg of proteinase K, followed by incubation at 37°C for 20 min. The reac- 
tions were phenol extracted, ethanol precipitated, and dissolved in the load- 
ing buffer.  The protected fragments were denatured and analyzed on a 7% 
polyacrylamide/urea gel. 
Preparation of  Antibodies against Synthetic Peptides 
Synthetic peptides 5'-1 (a mixture of three peptides a [EAENSQHQQKEE- 
GEE(=],  b  [AINSGQQEPQQEESC],  and ab' [KEEGEEAINSGQQEPQ- 
QEESC]) were derived from the predicted amino-terminal end of the larger 
4.1  isoform (see Fig. 3 D). Synthetic peptides 30b (GSYTIQSELGDYD- 
PELHGVDYVSDC),  16a  (TQAQTRQASALIDRPAPHFERC),  and  24a 
(GVLLTAQTITSETPSSTTTTKITKC)  were derived from the 30-, 16-, and 
24-kD domain of erythroid protein 4.1. Synthetic peptides were made with 
additional  cysteine residues  in  their  COOH-terminal  ends.  Antibodies 
against these peptides were raised in rabbits after conjugation to keyhole 
limpet  hemocyanin.  The  peptide-specific antibodies  were  purified  by 
affinity chromatography on immobilized synthetic peptides as described 
(Correas et al., 1986b).  Rabbit polyclonal antibodies to human erythrocyte 
protein 4.1 were prepared using standard ~,chniques of immunization as de- 
scribed earlier (Tang et al., 1988).  Human erythrocyte protein 4.1 was pre- 
pared and purified as described (Leto et al.,  1986b). 
In Vitro Translation and lmmunoprecipitation 
Two clones, pLym and pEry2, were constructed from pTM-l and -2. pLym 
(-I, +II,  -III,  +IV, -V), spanning all five motifs, contains Motif II and 
a new potential translation initiation site which is located within Motif IV. 
Table L Oligonucleotides Used  for Detecting Motifs in cDNA Libraries 
Motif  Sense  Motif  Antisense 
IS  5'AAGGAAGACGAGCCACCT3'  IAS 
IIS  5'AGACGTCCCTATTGTCCA3'  IIAS 
IIIS  5'ATGCACTGCAAGGTTTCT3'  IIIAS 
VS  5'AAGGTGAAGGAGGTCAG3'  VAS 
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RI and Hind III fragment which contains Motif IV from pLym, and contains 
only the interior translation initiation site. Synthetic sense-capped mRNAs 
were generated from the SP6 or T7 promoter within the vector. Briefly, 
these components were added in the following order: 6 #1 diethylpyrocar- 
bonate-treated water, 5/~1 5x transcription buffer (200 mM Tris-HCl, pH 
7.5/30  mM MgCI2/10 mM Spermidine/50 mM NaCI), 2.5 #1 0.1 M  DTT, 
40/U RNasin ribonuclease inhibitor, 5  td  rNTP (2.5  mM ATP/2.5  mM 
CTP/2.5 mM UTP/0.25  mM GTP), 1.25 #1 2.5 mM m7G(5')ppp(53G (RNA 
cap structure analog), 0.2-1 #g linearized DNA, 2 U SP6 or T7 RNA poly- 
merase (Promega Biotec). Incubation was performed at 40°C for I h. The 
sense mRNAs were translated in a rabbit reticulocyte system (Promega Bio- 
tec),  in the presence of 35S-methionine,  to radiolabel newly synthesized 
proteins. In vitro translation products or immunoprecipitates obtained with 
antibodies against synthetic peptides were resolved on SDS-polyacrylamide 
gels and visualized by fluorography as described (Davis et al.,  1986). 
lmmunoblot Analysis 
Solubilized proteins in hot SDS from MOLT 4 cells, and human red cell 
ghosts were prepared as described (Tang et al., 1988).  Solubilized proteins 
were separated by SDS-PAGE and blotted onto nitrocellulose, probed with 
primary  antibodies,  and  then detected with  t25I-labeled  Staphylococcus 
protein A (Tang et al., 1988) or an anti-rabbit IgG, which had been alkaline 
phosphatase conjugated (Promega Biotec). 
Results 
Diverse Structures of cDNA Clones Encoding Multiple 
Forms of  Protein 4.1 in Erythroid and Lymphoid Cells 
Our  initial  goal was to characterize the genes that encode 
different protein 4.1  isoforms in erythroid and nonerythroid 
forms.  As  discussed  below,  we  isolated  cDNAs  whose 
nucleotide  sequences  were consistent  with the  notion  that 
there is only one gene for protein 4.1. Multiple isoforms arise 
by alternative mRNA splicing. We present the characteriza- 
tion of five sequence regions or cassettes, called Motifs I-V, 
that distinguish different isoforms. We also show that a novel 
high molecular weight isoform predicted by these cDNA se- 
quences can be detected in some cells by antibodies derived 
from deduced peptide sequences. 
Fig.  1 shows a  molecular model for the structure of the 
prototypical erythroid protein 4.1  species based on mRNA 
sequence, partial amino acid sequence data, and functional 
analysis (Leto et al.,  1986a).  The  regions of the  putative 
glycophorin and spectrin/actin binding sites are indicated, as 
are the distribution of phosphates and clustered sulfhydryl 
groups. 
Fig.  2  diagrams  the  structure  of several  representative 
cDNAs obtained from erythroid and nonerythroid sources 
(details  of these  clones  are  not  shown).  All  cDNAs  were 
identical to one another along the bulk of sequence, and se- 
quence differences were limited to five regions ranging in 
size from 17 to 105 nucleotides. These are indicated as open 
or closed blocks labeled Motifs I-V in Fig.  2  (a black box 
indicates that the sequence is present in the cDNA clones; 
an open box indicates that the sequence is absent). The com- 
plete nucleotide sequence of an mRNA in which all five of 
the  sequence blocks are retained  has been published else- 
where (Tang et al.,  1988;  Tang, T. K., E. J.  Benz, Jr., and 
V.  T.  Marchesi,  manuscript in preparation). 
The patterns of variation outlined in Fig. 2 are most con- 
sistent with one or a  few copies of a  protein 4.1  gene; the 
diversity of mRNA transcripts would then be generated by 
alternative  mRNA  splicing.  Southern  blot  analysis of ge- 
Figure 2. Summary of  the diverse protein 4.1 cDNA clones isolated 
from the cDNA libraries of different source of tissues.  (A) Struc- 
tural domains of human erythrocyte protein 4.1. (B) Five different 
nucleotide sequence motifs (I-V) identified in protein 4.1 mRNAs. 
(C) Diverse structure of protein 4.1 cDNA clones isolated from hu- 
man lymphoid  (MOLT 4),  fetal liver,  and bone  marrow  cDNA 
libraries.  An open block indicates the  sequence  is absent  in the 
cDNA clones; a solid block indicates that the sequence is pi'esent. 
The detailed structures of the clones are not shown; the sequence 
data are being prepared  for publication. 
nomic DNA reveals one or at most a very few copies of the 
4.1  gene  (our  unpublished  results;  Tchernia  et  al.,  1981; 
Ngai et al., 1987; Conboy et al.,  1988). The gene copy num- 
ber is certainly not sufficient to account for the diversity of 
mRNA sequences observed. 
The five sequence blocks that differentiate transcripts from 
one another have been provisionally named Motifs I-V, in the 
order of their discovery (Fig. 3 D). Motif I is 63 nucleotides 
long,  encoding  a  21-amino acid  segment within  a  10-kD 
spectrin/actin binding domain. MotiflI (102 nucleotides) en- 
codes a 34-amino acid segment near the COOH end of the 
22/24-kD  domain.  Motif III (105  nucleotides)  encodes  a 
35-amino acid peptide near the amino-terminal end of the 
30-kD domain. Although this domain includes the glycopho- 
rin binding region, precise localization of this function in the 
30-kD segment has not been established. 
Motifs IV and V (Fig. 3 D) can exert more complex effects 
on the structure and function of protein 4.1  mRNA. The 5' 
untranslated sequence of the prototypical protein 4.1 mRNA 
contains  a  long  open  reading  frame  (ORF) t  contiguous 
with the ORF-2 in the figure. ORF-2 is translatable from the 
indicated  initiator  methionine  into  an  80-kD polypeptide. 
1.  Abbreviations used in this paper:  nt,  nucleotide; ORE  open reading 
frame. 
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and alignment of synthetic peptides used for generation of site- 
specific antibodies. (A) Structural domains of human erythrocyte 
protein 4.1. (B) Erythroid protein 4.1  eDNA clone reported by 
Conboy et al. (1986a). (C) ORF-I and -2 found in erythroid 4.1 se- 
quence, are indicated by the open boxes. The boxes with vertical 
lines indicate that there are no other long ORFs in ORF-1 or -2. 
ORF-1 begins by counting codons from base 1 of  our most upstream 
eDNA; ORF-2, from base 2. (D) Variable motifs (l-V) defined by 
comparison of erythroid  (Conboy et al.,  1986a) and  lymphoid 
eDNA sequence. Synthetic peptides, 5'-1, 30b, 16a, and 24a, are 
described in detail in Materials and Methods. 
All three possible reading frames contain translation termi- 
nation codons. Every possible reading frame is thus ~closed'; 
that is, it cannot be translated. Moreover, there is no initiator 
methionine in the remaining known 5' untranslated sequence. 
However, we identified cDNAs that differed at the extreme 
5' end by the addition of Motif IV and the deletion of Motif 
V. Removal of the 80 bases within Motif V deletes several 
termination codons and shifts the reading frame by 1 base. 
Inclusion of Motif IV in the mRNA introduces a methionine 
codon surrounded by a  strong consensus translation initia- 
tion signal (Kozak,  1984); moreover, the combination of a 
17-base insert (Motif IV) and an 80-base deletion (Motif V) 
shifts the reading frame in such a way that, counting from 
the A of the ATG of the new upstream methionine codon, 
there are no termination codons encountered between this 
methionine and the initiator methionine of the 80-kD pro- 
tein. The open reading frame is thus continuous. 
Inclusion of Motif IV and deletion of Motif V, when oc- 
curring in concert, have the potential to generate a new pro- 
tein  4.1  isoform having  a  higher  molecular weight.  This 
additional  coding  sequence adds  209  amino acids  to  the 
amino-terminal end of the prototypical 4.1  (80-kD) mole- 
cule. Initiation at the upstream methionine would then gener- 
ate a larger protein within which the COOH-terminal 80 kD 
represents the prototypical 4.1  molecule. 
cDNAs outlined in Fig. 2 thus establish the structure of 
several distinctive protein 4.1  mRNAs and predict the exis- 
tence of many heterogeneous isoforms. Moreover, the iden- 
tification of these five sequence motifs provide for the struc- 
tural bases for at least 32 mRNAs,  from which  16 distinct 
protein isoforms can be generated. (Since Motif IV and Mo- 
tif V muct act in concert to generate additional protein iso- 
forms, there can be more mRNAs than proteins.) 
Expression of  Multiple Protein 4.1 mRNAs in 
Erythroid and Nonerythroid Cells 
To detect protein 4.1  mRNAs expressed in various tissues 
and species, we developed nucleic acid probes for mRNAs 
containing or lacking specific motifs. Poly(A)  + mRNA and 
total RNA  were isolated from human erythroid and non- 
erythroid cells and analyzed either by Northern blot hybrid- 
ization or RNase protection analysis (Fig. 4). Northern blots 
were analyzed with  lymphoid 4.1  eDNA  probe  (pTM-I). 
RNase protection analysis was performed with synthetic RNA 
probes containing the appropriate motifs, thereby generating 
protected fragments of diagnostic size. 
Fig. 4  shows the results of RNase protection analysis in 
erythroid and nonerythroid cells. As indicated by Fig. 4 A, 
the 156-nt (nucleotide) protected fragment indicated the pres- 
ence of an mRNA containing Motif IV; the 117-nt and 22-nt 
fragments indicated expression of an mRNA lacking Motif 
IV. The weak 22-nt band, because of its small size and conse- 
quent lower content of radioactive label, was not detected. 
Fig.  4  A also shows  that at least two types of protein 4.1 
mRNAs  (with or without Motif IV)  were produced from 
MOLT 4 and HEL cells. About two thirds of the protein 4.1 
mRNA contains Motif IV in MOLT 4  cells.  This result is 
consistent with the finding of two independent eDNA clones, 
containing  (pTM-2)  or  lacking  (pTM-5)  Motif IV,  which 
were isolated from the MOLT 4 eDNA library (Fig. 2  C). 
In contrast, the dominant protected fragment (ll7nt)  indi- 
cated that the major species of protein 4.1 mRNA produced 
from human reticulocytes lacks Motif IV (Fig. 4 A). How- 
ever, upon long exposure (5 d; data not shown), a  minute 
amount of reticulocyte RNA containing Motif IV could be 
detected. This weak protected band  (156nt)  accounted for 
<5% of total protein 4.1  mRNA; it may represent residual 
mRNA from earlier maturation stages or from contaminat- 
ing RNA from residual nucleated cells in the original reticu- 
Iocyte preparation. The multiple-banding pattern shown in 
Fig. 4 A could arise from nuclease digestion artifacts, or in- 
dicate potential additional motifs in that region. 
In contrast to the distribution of Motif IV, mRNA contain- 
ing Motifs III (the protected fragment is 345 nt) or II (340 
nt)  represent well over 90%  of the mRNA  found in both 
erythroid and nonerythroid cells (Fig. 4, B and  C). 
Expression of  Protein lsoforms in Nonerythroid Cells 
Analysis of nonerythroid protein 4.1 mRNAs (Fig. 4 A) sug- 
gested that the majority (two thirds) of the mRNA contained 
Motif IV, and thus possess the potential for translation into 
higher molecular weight  isoforms.  To determine whether 
this mRNA was expressed in the form of higher molecular 
weight protein, we isolated total protein from MOLT 4 cells. 
Purified erythroid protein 4.1  and  synthetic peptides that 
were derived from the deduced amino acid sequences of the 
30-,  (30b),  16-,  (16a), and 24-kD (24a) domain were pre- 
pared (Fig.  3 D).  Polyclonal antisera against the erythroid 
4.1  and peptides were raised and purified as described in 
Materials and Methods. 
Fig.  5  shows  immunoblot analysis of 4.1  proteins from 
MOLT 4 cells. At least two major protein 4.1 isoforms corre- 
sponding to peptide chains of '~135 and 80 kD were iden- 
tified in MOLT 4 cells. Both proteins strongly react with an- 
tibodies against  intact erythroid protein 4.1  and  synthetic 
The Journal  of Cell Biology, Volume 110, 1990  620 Figure 4. Detection of erythroid and nonerythroid protein 4.1 mRNAs by RNase protection assay. Specific antisense probes were designed 
by constructing sequence-specific eDNA clones that contain specific motifs. The eDNA inserts of  these clones were subcloned into a pGEM- 
4 or -7Z vector, which contains SP6 or T7 RNA polymerase promoters.  Antisense RNAs were generated from the T7 promoter within 
the vector. Total RNAs (30/Lg) from different tissues or cell lines were hybridized to the antisense probes that span Motif IV (A), Motif 
III (B), or Motif II (C). HR, human reticulocyte; HL60, human promyelocytic leukemia line; CHO, Chinese hamster ovary line; HEL, 
human erythroleukemia  line; MOLT 4, human T cell leukemia line; HeLa, human epithelioid carcinoma line. Bars denote ~X174  Hae 
III--digested DNA size markers (M). The positions of size markers are indicated in nucleotide. 
peptides (3Oh, 16a, and 24a). Interestingly, higher molecular 
weight forms were also detected on the blot with anti-16a and 
-24a antibodies (Fig.  5,  lanes 3  and 4). 
In Vitro Translation of Synthetic Full-Length mRNAs 
Encoding Protein 4.1 
AS noted earlier, the 80-kD protein 4.1 mRNA has two large 
ORFs (Fig.  3  C) that are not aligned in phase and are dis- 
rupted in the 5' untranslated region by several translation stop 
codons. Insertion of Motif IV and deletion of Motif V in the 
same mRNA species creates a new ORF continuous and in 
phase with  ORF-2  (ORF-2  generates  the  80-kD  protein). 
The new reading frame has a potential to encode a larger pro- 
tein species. As shown in Fig. 5, immunochemical analysis 
demonstrated that cells contain high molecular weight pro- 
teins. To verify that the mRNA could be translated into a pro- 
tein of predicted sequence,  i.e.,  that the upstream initiator 
methionine functions and that the reading frame is indeed 
open,  we  constructed  cDNAs  containing  and  lacking  the 
translatable  configurations  of  Motifs  IV  and  V.  These 
cDNAs  were  then  transcribed  into  synthetic  mRNA,  and 
translated in a cell-free system. Fig. 6 shows immunoprecipi- 
ration analysis of the  translation  products  with  antibodies 
against the 5' upstream regions. Fig. 7 compares the sizes of 
in  vitro products  to protein  isolated  from intact cells.  AS 
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sis  of lymphoid  protein  4.1 
isoforms.  Solubilized  pro- 
teins from MOLT 4 cells were 
separated by SDS-PAGE and 
blotted onto nitrocellulose  as 
described (Tang et al., 1988). 
Blotted proteins were probed 
with  polyclonal  antiintact 
erythroid  4.1  (lane  I), anti- 
30b  (lane  2),  -16a  (lane  3), 
and -24a (lane 4) antibodies, 
and  detected  by  ~25I-labeled 
Staphylococcus protein A (Cor- 
reas et ai.,  1986b). The low 
molecular  weight  band  has 
not yet been characterized. 
shown in  Fig.  6  (lane 8),  the  full-length lymphoid cDNA 
(pLym) spanning  all  five sequence  motifs and  containing 
both translation initiation codons gave rise to a  135- and an 
80-kD protein in the cell-free translation system. 
To further identify these in vitro translated proteins, an im- 
munoprecipitation assay was performed. A synthetic peptide 
mixture, 5'-1 (a mixture of three peptides a, b, and ab' shown 
in Fig. 3 D), was prepared. The 5'-1 peptides were derived 
from the predicted amino-terminal translated sequence of the 
larger 4.1  isoform, whose synthesis begins with the methio- 
nine within the  17-base Motif IV. Polyclonal antisera were 
raised against these peptides, purified, and characterized as 
described  in  Materials  and  Methods.  As  shown  in  Fig.  6 
(lanes  1  and  2),  the  135-  and  80-kD  translated  proteins 
reacted strongly with antiintact erythroid 4.1 antibody. How- 
ever, only the  135-kD protein was detected when anti-5'-I 
antibody was used as a probe (Fig. 6, lane 4). Interestingly, 
the in vitro-translated proteins (135  and 80 kD) comigrate 
with proteins that were isolated from MOLT 4 cells (Fig. 7, 
lanes 3  and 4). 
A truncated cDNA (pEry 2) from which the initiator me- 
thionine  in the  17-base motif had been excluded could be 
translated only into the 80-kD protein (Fig.  6,  lanes 1 and 
7; Fig.  7, lane 2). When both initiator codons were present, 
initiation of the upstream site was strongly favored (Fig. 6, 
lanes 2 and 8; Fig. 7, lane 3); however, the downstream initi- 
ator methionine is also a potentially strong initiation signal, 
since it is translated efficiently into the protein in the mes- 
sage lacking Motif IV (Fig. 6, lanes I  and 7; Fig. 7, lane 2). 
It is interesting to note that the primary sequence of the 
lymphoid 4.1 clone (pLym) predicts a polypeptide with a cal- 
culated molecular mass of 100,534 D. However, the apparent 
size of the in vitro-translated protein (135 kD) seen on SDS- 
PAGE was much larger. This discrepancy may be due in part 
to aberrant migration in SDS-PAGE. 
Figure 6. Analysis of synthetic protein 4.1  mRNAs translated in 
vitro. Two transcription 4.1 clones, a pLym clone that contains the 
first  two translation  initiation  codons  (AUG),  and  a  truncated 
clone, pEry2, which removed Motifs IV and V, were constructed 
and subcloned into a pGEM-4 vector (see Materials and Methods). 
Sense-capped mRNA transcripts were translated in vitro by adding 
rabbit reticulocyte  lysate and 35S-methionine. The labeled trans- 
lated proteins were either immunoprecipitated by antierythroid 4.1 
antibody (lanes 1 and 2), anti-5'-I (lanes 3 and 4), preimmune se- 
rum (lanes 5 and 6), or direct analysis on NaDodSO4/PAGE (lanes 
7 and 8). Lanes 1, 3, 5, and 7 are the proteins translated in vitro 
from pEry2 clone. Lanes 2, 4, 6, and 8 are translated proteins from 
pLym clone. 
Figure 7. Immunoblot analysis of protein 4.1 isoforms expressed in 
vitro and in vivo. Piym and pEry2 clones were transcribed  and 
translated  in vitro as described  in Materials  and  Methods.  The 
translated proteins were resolved in SDS-PAGE and blotted onto 
nitrocellulose  as described  (Tang et al.,  1988). Blotted proteins 
were probed with a mixture of anti-16a and -24a antibodies and de- 
tected with a goat anti-rabbit IgG alkaline phosphatase conjugat~l 
as described in Pmmega Biotec manual.  (Lane I) rabbit reticulo- 
cyte lysate; (lane 2) translated proteins from pEry2 clone; (lane 3) 
translated proteins from pLym  clone; (lane 4) total solubilized pro- 
teins from MOLT 4 cells. 
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Previous studies have provided indirect evidence for the exis- 
tence of multiple isoforms of protein 4.1 in human (Tang et 
al., 1988; Conboy et al.,  1988) and avian species (Granger 
and  Lazarides,  1984).  These  forms are  immunologically 
cross-reactive,  expressed  in  many  tissues,  and  heteroge- 
neous with respect to size and relative abundance of size 
classes. Moreover, localization of protein 4.1 by immunocy- 
tochemical methods suggested that these isoforms might be 
distributed in and around the nucleus (Tang,  T.  K., E. J. 
Benz, Jr., and V. T. Marchesi, manuscript in preparation; 
Leto et al.,  1986b)  and along stress fibers (Cohen et al., 
1982), as well as under the cytoplasmic membrane. Our data 
established the existence of multiple protein 4.1 isoforms in 
erythroid and nonerythroid tissues, and provide a structural 
basis for many of these forms. Protein 4.1 appears to be a 
protein family arising from a multiplicity of messenger RNAs 
generated by alternative mRNA processing. 
A novel result of our studies, not anticipated by previous 
work, was the existence of a high molecular weight class of 
protein 4.1 isoforms generated from the same gene by alter- 
nate splicing events that convert the 5' untranslated extremity 
of the mRNA into a translatable reading frame contiguous 
with the known 80-kD open reading frame of erythroid pro- 
tein 4.1. As shown in Figs. 6 and 7, we have documented that 
this potentially usable ORF is in fact translated into protein 
both in cell-free translation extracts and in intact cells ex- 
pressing the endogenous gene. The protein can be uniquely 
identified by an antipeptide antibody that we have generated 
on the basis of novel amino-terminal peptides translatable 
into protein only if the appropriate mRNA splicing events 
occur.  The  size of the protein  isolated from whole cells 
agrees closely with the size of the primary translation prod- 
uct generated in the cell-free system. It is interesting that this 
high molecular weight protein is abundant in the nucleus as 
well as along submembranous sites at intercellular junctions 
(Tang, T. K., E. J. Benz, Jr., and V. T. Marchesi, manuscript 
in preparation). We postulate that protein 4.1  isoforms are 
important for assembly and function of skeletal structures 
within the nucleus, as well as the cytoplasm. 
Protein 4.1 mRNAs capable of encoding both a  135- and 
80-kD protein could be translated in vitro (Fig. 6), but we 
have not yet documented whether both translation initiation 
sites are used in vivo. It is interesting that the upstream initia- 
tor methionine is used almost exclusively when present, but 
that the downstream initiator works quite efficiently if it is 
the  methionine encountered closest to  the  5'  end  of the 
mRNA. This naturally occurring bifunctional mRNA should 
prove useful for studies of factors regulating the positioning 
of translation initiation. 
Our sequence analysis of protein 4.1 cDNAs provides for 
as many as 32 mRNA species arising from a single mRNA 
precursor.  Only 16 of these mRNAs would be translatable 
into  protein,  because  only one combination of insertion 
and/or deletion of Motifs IV and V is compatible with trans- 
lation of  the larger isoform. Our studies of mRNA accumula- 
tion in various types of cells suggests that mRNAs capable 
of encoding the larger isoform comprise nearly two thirds of 
protein 4.1 mRNAs in MOLT 4 cells (Fig. 4 A). mRNAs con- 
taining Motif  I are expressed predominantly in erythroid tis- 
sues (Tang et al.,  1988), while mRNAs containing Motif II 
(Fig. 4 C) and/or Motif III (Fig. 4 B) comprise over 90% 
of the mRNAs we have been able to identify. Recently, Con- 
boy et al.  (1988) have identified another motif (43  amino 
acids) just in front of Motif II in reticulocyte 4.1 sequence. 
However,  this motif is present in all of our erythroid and 
nonerythroid eDNA clones. These results demonstrate that 
several protein 4.1 isoforms are actually produced in reason- 
able abundance in many cell types; however,  considerably 
fewer forms may accumulate than are theoretically possible 
on the basis of potential alternate mRNA splicing events. In 
contrast, erythroid cells (human reticulocytes) contain very 
little protein 4.1 mRNA encoding the larger isoform (Fig. 4 
A) but do produce isoforms expressing Motif I (Tang et al., 
1988).  Posttranslational modification of isoforms, such as 
proteolytic fragmentation, glycosylation (known to occur 
via cytoplasmic glycosylation enzymes [Holt et al., 1987]), 
or phosphorylation may need to be invoked to explain all of 
the forms encountered. It is entirely possible, of course, that 
tissues or cell types not yet screened by us may express one 
of the rare forms of protein 4.1  in greater abundance. 
Protein 4.1 is a bifunctional protein, attaching to the cyto- 
plasmic domain of transmembrane  proteins  (glycophorin 
and band 3) at its amino-terminal end, and to cytoskeletal 
structures (spectrin/actin complexes) by means of the 10-kD 
domain. Function appears to be regulated by phosphoryla- 
tion. It is important to note that these functions, as well as 
the assignments of functions to specific domains, have been 
delineated only for erythroid forms of the protein 4.1 in sys- 
tems using membrane cytoskeletal elements derived from 
erythroid  cells.  The  function  of  isoforms  expressed  in 
nonerythroid tissues remains an open question. We have re- 
cently obtained evidence suggesting that retention of Motif 
I  is important for binding of the protein 4.1  molecule to 
erythroid spectrin/actin complexes (our unpublished data). 
Therefore, it is entirely possible that protein 4.1  interacts 
with distinct components in nonerythroid tissues. This may 
account for its unexpected tissue distribution. The sequence 
motifs that we have identified could well contain functional 
cassettes that mediate novel functions of the protein. These 
motifs represent logical targets for future in vitro mutagene- 
sis studies designed to delineate the structural basis for the 
unusual distribution of protein 4.1 isoforms in nonerythroid 
cells. 
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